methyl 2-(2-methylallyloxy)-5-methoxy-1H-indole-3-carboxylate | 1092486-12-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: methyl 2-(2-methylallyloxy)-5-methoxy-1H-indole-3-carboxylate
• 英文别名: methyl 5-methoxy-2-(2-methylprop-2-enoxy)-1H-indole-3-carboxylate
• CAS: 1092486-12-8
• 化学式: C₁₅H₁₇NO₄
• 分子量: 275.304
• InChiKey: TVTDCKWFLLAEAD-UHFFFAOYSA-N

物化性质

• 沸点：
  450.1±40.0 °C(predicted)
• 密度：
  1.185±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  20
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  60.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 2-(2-methylallyloxy)-5-methoxy-1H-indole-3-carboxylate 在 palladium on activated charcoal 、 氢气 、 2,6-双[(3aS,8aR)-3a,8a-二氢-8H-indeno[1,2-d]恶唑啉-2-基]吡啶 、 scandium tris(trifluoromethanesulfonate) 作用下， 以 甲醇 、 1,2-二氯乙烷 为溶剂， 反应 24.0h， 生成
  参考文献：
  名称：

  Scan（III）催化的克莱森重排反应的不对称合成3-烯丙基氧吲哚和3-烯丙基氧吲哚

  摘要：

  在温和的反应条件下，催化的2-烯丙氧基吲哚和2-炔丙氧基吲哚的不对称克莱森重排反应提供了一种新颖的方法，以优异的收率（高达99％）和对映选择性（高达ee的99％）对各种3-烯丙氧基吲哚和3-烯丙基氧吲哚进行了反应。 。catalyst催化剂衍生自Sc（OTf）3和Pybox配体。

  DOI：

  10.1002/cjoc.201700486
• 作为产物：
  描述：

  5-甲氧基-1H-吲哚-3-甲酸甲酯 、 2-甲基-2-丙烯-1-醇 在 三乙烯二胺 、 N-氯代丁二酰亚胺 、 二甲基砜 作用下， 以 二氯甲烷 为溶剂， 反应 7.0h， 以59%的产率得到methyl 2-(2-methylallyloxy)-5-methoxy-1H-indole-3-carboxylate
  参考文献：
  名称：

  Scan（III）催化的克莱森重排反应的不对称合成3-烯丙基氧吲哚和3-烯丙基氧吲哚

  摘要：

  在温和的反应条件下，催化的2-烯丙氧基吲哚和2-炔丙氧基吲哚的不对称克莱森重排反应提供了一种新颖的方法，以优异的收率（高达99％）和对映选择性（高达ee的99％）对各种3-烯丙氧基吲哚和3-烯丙基氧吲哚进行了反应。 。catalyst催化剂衍生自Sc（OTf）3和Pybox配体。

  DOI：

  10.1002/cjoc.201700486

文献信息

• Catalytic Enantioselective Meerwein−Eschenmoser Claisen Rearrangement: Asymmetric Synthesis of Allyl Oxindoles
  作者：Elizabeth C. Linton、Marisa C. Kozlowski

  DOI：10.1021/ja807026z

  日期：2008.12.3

  The first catalytic, enantioselective Meerwein-Eschenmoser Claisen rearrangement has been achieved. Palladium(II) BINAP or phosphinooxazoline catalysts were employed to generate oxindole products with 100% conversion and up to 92% ee.

  第一个催化、对映选择性 Meerwein-Eschenmoser Claisen 重排已经实现。钯 (II) BINAP 或膦基恶唑啉催化剂用于生成 100% 转化率和高达 92% ee 的羟吲哚产品。
• INDOLE AND AZAINDOLE DERIVATIVE HAVING AMPK-ACTIVATING ACTIVITY
  申请人：SHIONOGI & CO., LTD

  公开号：US20150203450A1

  公开（公告）日：2015-07-23

  Disclosed is a compound which is useful as an AMPK activator. A compound represented by formula: or its pharmaceutically acceptable salt, wherein Y is substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, or substituted or unsubstituted heterocyclyl; T is —CR 7 ═ or —N═; U is —CR 8 ═ or —N═; R 2 is hydrogen, halogen, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted acyl, substituted or unsubstituted carbamoyl, substituted or unsubstituted alkylthio, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkylsulfonyl, or substituted or unsubstituted alkyloxycarbonyl; R 3 is halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocyclyl, or the like; and R 4 , R 7 and R 8 are each independently hydrogen, halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocyclyl, or the like.

  本申请公开了一种作为AMPK激活剂有用的化合物。一种由以下结构表示的化合物或其药学上可接受的盐，其中Y被取代或未取代的烷基，取代或未取代的烯基，取代或未取代的炔基，取代或未取代的芳基，取代或未取代的杂环芳基，取代或未取代的环烷基，取代或未取代的环烯基，或取代或未取代的杂环烷基；T为—CR7═或—N═；U为—CR8═或—N═；R2为氢，卤素，氰基，硝基，羧基，取代或未取代的烷基，取代或未取代的烯基，取代或未取代的酰基，取代或未取代的氨基甲酰基，取代或未取代的烷基硫基，取代或未取代的烷基亚砜基，取代或未取代的烷基砜基，或取代或未取代的烷氧羰基；R3为卤素，取代或未取代的烷基，取代或未取代的烯基，取代或未取代的炔基，取代或未取代的芳基，取代或未取代的杂环芳基，取代或未取代的环烷基，取代或未取代的环烯基，取代或未取代的杂环烷基，或类似物；且R4、R7和R8分别独立地为氢，卤素，羟基，氰基，硝基，羧基，取代或未取代的烷基，取代或未取代的烯基，取代或未取代的炔基，取代或未取代的芳基，取代或未取代的杂环芳基，取代或未取代的环烷基，取代或未取代的环烯基，取代或未取代的杂环烷基，或类似物。
• INDOLE AND AZAINDOLE DERIVATIVES EACH HAVING AMPK-ACTIVATING ACTIVITY
  申请人：Shionogi & Co., Ltd.

  公开号：EP2963013A1

  公开（公告）日：2016-01-06

  Disclosed is a compound which is useful as an AMPK activator. A compound represented by formula: or its pharmaceutically acceptable salt, wherein Y is substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, or substituted or unsubstituted heterocyclyl; T is -CR7= or -N=; U is -CR8= or -N=; R2 is hydrogen, halogen, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted acyl, substituted or unsubstituted carbamoyl, substituted or unsubstituted alkylthio, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkylsulfonyl, or substituted or unsubstituted alkyloxycarbonyl; R3 is halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocyclyl, or the like; and R4, R7 and R8 are each independently hydrogen, halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocyclyl, or the like.

  本发明公开了一种可用作 AMPK 激活剂的化合物。一种由式表示的化合物： 或其药学上可接受的盐、 其中 Y 是取代或未取代的烷基、取代或未取代的烯基、取代或未取代的炔基、取代或未取代的芳基、取代或未取代的杂芳基、取代或未取代的环烷基、取代或未取代的环烯基、取代或未取代的杂环基； T 是-CR7= 或-N=； U 是-CR8= 或-N=； R2 是氢、卤素、氰基、硝基、羧基、取代或未取代的烷基、取代或未取代的烯基、取代或未取代的酰基、取代或未取代的氨基甲酰基、取代或未取代的烷硫基、取代或未取代的烷硫基、取代或未取代的烷磺酰基、取代或未取代的烷氧羰基； R3 是卤素、取代或未取代的烷基、取代或未取代的烯基、取代或未取代的炔基、取代或未取代的芳基、取代或未取代的杂芳基、取代或未取代的环烷基、取代或未取代的环烯基、取代或未取代的杂环基，或类似物；和 R4、R7 和 R8 各自独立地为氢、卤素、羟基、氰基、硝基、羧基、取代或未取代的烷基、取代或未取代的烯基、取代或未取代的炔基、取代或未取代的芳基、取代或未取代的杂芳基、取代或未取代的环烷基、取代或未取代的环烯基、取代或未取代的杂环基或类似物。
• Copper(II)- and Palladium(II)-Catalyzed Enantioselective Claisen Rearrangement of Allyloxy- and Propargyloxy-Indoles to Quaternary Oxindoles and Spirocyclic Lactones
  作者：Trung Cao、Elizabeth C. Linton、Joshua Deitch、Simon Berritt、Marisa C. Kozlowski

  DOI：10.1021/jo302039n

  日期：2012.12.21

  In this Article, a strategy to obtain highly enantio-selective catalysts for the Claisen rearrangement of allyloxy- and propargyloxy-indoles is outlined. Ultimately, copper BOX and palladium BINAP or PHOX catalysts were discovered as superior in catalyzing Claisen rearrangements of allyloxy- or proparyloxy-substituted indoles to generate oxindoles bearing allyl- or allenyl-substituted quaternary centers. This method proved to be tolerant of a broad range of functional groups. Tandem reactions of the silyl-allene products provide rapid access to a variety of spirocyclic oxindoles in one operation.
• US9890119B2
  申请人：——

  公开号：US9890119B2

  公开（公告）日：2018-02-13